Released: June 15, 2015

Defense Health Program
Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program
Upcoming Funding Opportunity

The FY15 Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program is funded with Congressional Appropriations to support innovative research committed to complement and further ongoing DoD efforts to ensure the health and readiness of our military forces. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Congressionally Directed Medical Research Programs (CDMRP) with strategic oversight from Joint Program Committee 5 (JPC5)/Military Operational Medicine Research Program (MOMRP).

The PH/TBI Research Program is providing the information in this pre-announcement to allow investigators time to plan and develop applications. The Comprehensive Universal Prevention/Health Promotion Interventions and Systems-level Approaches (FY15 CUP/HPI) Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on the website in July 2015. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government.

Award Mechanism Eligibility Key Mechanism Elements Funding
Applied Research and Clinical Trials Independent investigators at all academic levels (or equivalent)
  • A pre-application is required
  • The FY15 CUP/HPI Award intent is to support research focused on the development, adaptation, efficiency or optimization, and testing of comprehensive universal prevention/health promotion interventions and systems-level approaches for use within the military context.
  • The Program Announcement seeks research applications intended to support both applied research and clinical trials that are designed to have positive effects on multiple target behaviors and outcomes.
  • The maximum funding available for this award is $7,500,000 in direct plus indirect costs.
  • Maximum period of performance is 3 years for applied research awards and 4 years for clinical trial awards

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the website. The application package containing the required forms for each award mechanism will also be found on A listing of all CDMRP funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government's single-entry portal, Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to For more information about the PH/TBI or other CDMRP-administered programs, please visit the CDMRP website (

Point of Contact:

CDMRP Public Affairs